TRPV1 and Alzheimer disease: Despite the reported beneficial effects of capsaicin against multiple AD‐related pathologies, the efficacy of capsaicin and other TRPV1 agonists as AD therapeutics should be carefully evaluated at both preclinical and clinical levels.